We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys and G7 Therapeutics Sign Alliance

News   Aug 06, 2015

 
MorphoSys and G7 Therapeutics Sign Alliance
 
 
 

RELATED ARTICLES

HIV Suppressed for up to Four Months by Novel Antibody

News

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months.

READ MORE

Arsenic Harnessed to Create Broad-Spectrum Antibiotic

News

Although it contains arsenic, researchers say they tested the antibiotic's toxicity on human blood cells and reported that “it doesn’t kill human cells in tissue culture.”

READ MORE

Turning Tumors Into Cancer Vaccine Factories

News

A novel approach to cancer immunotherapy involves injecting immune stimulants directly into a tumor to teach the immune system to destroy it and other tumor cells throughout the body.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE